ReviewJournal of clinical medicine2025

Balancing Safety and Efficacy: Factor XIa INHIBITORS vs. DOACs in Patients with Atrial Fibrillation: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.

Jacinthe Khater et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.